All terms in GO
| Label | Id | Description |
|---|---|---|
| octopamine receptor activity | GO_0004989 |
Combining with the biogenic amine octopamine to initiate a change in cell activity. Octopamine is found in both vertebrates and invertebrates and can have properties both of a hormone and a neurotransmitter and acts as an adrenergic agonist.
|
| regulation of thyroid hormone generation | GO_2000609 |
Any process that modulates the frequency, rate or extent of thyroid hormone generation.
|
| regulation of hormone metabolic process | GO_0032350 |
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving any hormone.
|
| positive regulation of Arp2/3 complex-mediated actin nucleation | GO_2000601 |
Any process that activates or increases the frequency, rate or extent of Arp2/3 complex-mediated actin nucleation.
|
| positive regulation of actin nucleation | GO_0051127 |
Any process that activates or increases the frequency, rate or extent of actin nucleation, the initial step in the formation of an actin filament in which actin monomers combine to form a new filament.
|
| obsolete regulation of interphase of mitotic cell cycle | GO_2000602 |
OBSOLETE. Any process that modulates the frequency, rate or extent of interphase of mitotic cell cycle.
|
| GO_2000600 | GO_2000600 | |
| positive regulation of secondary growth | GO_2000605 |
Any process that activates or increases the frequency, rate or extent of secondary growth.
|
| regulation of secondary growth | GO_2000603 |
Any process that modulates the frequency, rate or extent of secondary growth.
|
| 3-(2,3-dihydroxyphenyl)propanoate metabolic process | GO_1901790 |
The chemical reactions and pathways involving 3-(2,3-dihydroxyphenyl)propanoate.
|
| negative regulation of secondary growth | GO_2000604 |
Any process that stops, prevents or reduces the frequency, rate or extent of secondary growth.
|
| 3-(2,3-dihydroxyphenyl)propanoate catabolic process | GO_1901791 |
The chemical reactions and pathways resulting in the breakdown of 3-(2,3-dihydroxyphenyl)propanoate.
|
| 3-(2,3-dihydroxyphenyl)propanoate biosynthetic process | GO_1901792 |
The chemical reactions and pathways resulting in the formation of 3-(2,3-dihydroxyphenyl)propanoate.
|
| 3-(3-hydroxyphenyl)propanoate metabolic process | GO_1901793 |
The chemical reactions and pathways involving 3-(3-hydroxyphenyl)propanoate.
|
| 3-(3-hydroxyphenyl)propanoate catabolic process | GO_1901794 |
The chemical reactions and pathways resulting in the breakdown of 3-(3-hydroxyphenyl)propanoate.
|
| 3-(3-hydroxyphenyl)propanoate biosynthetic process | GO_1901795 |
The chemical reactions and pathways resulting in the formation of 3-(3-hydroxyphenyl)propanoate.
|
| oxytocin receptor activity | GO_0004990 |
Combining with oxytocin to initiate a change in cell activity.
|
| parathyroid hormone receptor activity | GO_0004991 |
Combining with parathyroid hormone to initiate a change in cell activity.
|
| platelet activating factor receptor activity | GO_0004992 |
Combining with platelet activating factor to initiate a change in cell activity.
|
| negative regulation of proteasomal protein catabolic process | GO_1901799 |
Any process that stops, prevents or reduces the frequency, rate or extent of proteasomal protein catabolic process.
|